ARLZ
Aralez Pharmaceuticals Inc.
ARLZ
ARLZ
Delisted
ARLZ was delisted on the 20th of August, 2018.
83 hedge funds and large institutions have $140M invested in Aralez Pharmaceuticals Inc. in 2016 Q3 according to their latest regulatory filings, with 15 funds opening new positions, 26 increasing their positions, 23 reducing their positions, and 27 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
83
Holders Change
-12
Holders Change %
-12.63%
% of All Funds
2.22%
Holding in Top 10
4
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.11%
New
15
Increased
26
Reduced
23
Closed
27
Calls
$1.03M
Puts
$2.16M
Net Calls
-$1.13M
Net Calls Change
-$2.1M
Top Buyers
| 1 |
ECP
Elk Creek Partners
Denver,
Colorado
|
+$3.04M |
| 2 |
TLCM
Tiger Legatus Capital Management
New York
|
+$2.23M |
| 3 |
CAD
Craig A. Drill
|
+$1.82M |
| 4 |
BC
Broadfin Capital
New York
|
+$1.46M |
| 5 |
D.E. Shaw & Co
New York
|
+$870K |
Top Sellers
| 1 |
JHIU
Janus Henderson Investors US
Denver,
Colorado
|
-$5.29M |
| 2 |
Vanguard Group
Malvern,
Pennsylvania
|
-$4.51M |
| 3 |
AC
Armistice Capital
New York
|
-$2.74M |
| 4 |
PI
Putnam Investments
Boston,
Massachusetts
|
-$1.82M |
| 5 |
Renaissance Technologies
New York
|
-$1.78M |